120 related articles for article (PubMed ID: 27638828)
1. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
Péchery A; Fauconnet S; Bittard H; Lascombe I
Tumour Biol; 2016 Nov; 37(11):14789-14802. PubMed ID: 27638828
[TBL] [Abstract][Full Text] [Related]
2. Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.
Elie-Caille C; Lascombe I; Péchery A; Bittard H; Fauconnet S
Mol Cell Biochem; 2020 Aug; 471(1-2):113-127. PubMed ID: 32519230
[TBL] [Abstract][Full Text] [Related]
3. PPARβ/δ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206.
Gu L; Shi Y; Xu W; Ji Y
Oncol Res; 2019 Aug; 27(8):923-933. PubMed ID: 30982495
[TBL] [Abstract][Full Text] [Related]
4. PPARβ/δ agonist GW501516 inhibits TNFα-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes.
Kim WJ; Lee W; Jung Y; Jang HJ; Kim YK; Kim SN
Biochem Biophys Res Commun; 2019 Mar; 510(4):621-628. PubMed ID: 30739791
[TBL] [Abstract][Full Text] [Related]
5. Activated PPARβ/δ Protects Pancreatic β Cells in Type 2 Diabetic Goto-Kakizaki Rats from Lipoapoptosis via GPR40.
Li J; Xu S; Liu Y; Yan Z; Zhang F; Lv Q; Tong N
Lipids; 2019 Oct; 54(10):603-616. PubMed ID: 31364177
[TBL] [Abstract][Full Text] [Related]
6. PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis.
Ji Y; Li H; Wang F; Gu L
Front Pharmacol; 2018; 9():648. PubMed ID: 30002625
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome Proliferator-Activated Receptor Beta/Delta Agonist Suppresses Inflammation and Promotes Neovascularization.
Tobita Y; Arima T; Nakano Y; Uchiyama M; Shimizu A; Takahashi H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722564
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes.
Zarei M; Barroso E; Palomer X; Escolà-Gil JC; Cedó L; Wahli W; Vázquez-Carrera M
Clin Investig Arterioscler; 2019; 31(3):111-118. PubMed ID: 30987865
[TBL] [Abstract][Full Text] [Related]
9. Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
Chistyakov DV; Astakhova AA; Goriainov SV; Sergeeva MG
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339154
[TBL] [Abstract][Full Text] [Related]
10. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A.
Faulkner A; Lynam E; Purcell R; Jones C; Lopez C; Board M; Wagner KD; Wagner N; Carr C; Wheeler-Jones C
Sci Rep; 2020 May; 10(1):7849. PubMed ID: 32398728
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231 breast cancer cells: Possible implication of the peroxisome proliferator-activated receptor β/δ abrogation.
Hirao-Suzuki M; Takeda S; Koga T; Takiguchi M; Toda A
J Toxicol Sci; 2020; 45(4):227-236. PubMed ID: 32238697
[TBL] [Abstract][Full Text] [Related]
12. PPARβ/δ Agonism Upregulates Forkhead Box A2 to Reduce Inflammation in C2C12 Myoblasts and in Skeletal Muscle.
Phua WWT; Tan WR; Yip YS; Hew ID; Wee JWK; Cheng HS; Leow MKS; Wahli W; Tan NS
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143325
[TBL] [Abstract][Full Text] [Related]
13. PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury.
Sarre C; Contreras-Lopez R; Nernpermpisooth N; Barrere C; Bahraoui S; Terraza C; Tejedor G; Vincent A; Luz-Crawford P; Kongpol K; Kumphune S; Piot C; Nargeot J; Jorgensen C; Djouad F; Barrere-Lemaire S
Stem Cell Res Ther; 2022 Apr; 13(1):167. PubMed ID: 35461240
[TBL] [Abstract][Full Text] [Related]
14. GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells.
Barbaud A; Lascombe I; Péchery A; Arslan S; Kleinclauss F; Fauconnet S
Cells; 2024 Apr; 13(8):. PubMed ID: 38667323
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of GW501516 and the role of Peroxisome proliferator-activated receptor β/δ and B-cell lymphoma 6 in inflammatory signaling in human pancreatic cancer cells.
Smith RW; Coleman JD; Thompson JT; Vanden Heuvel JP
Biochem Biophys Rep; 2016 Dec; 8():395-402. PubMed ID: 28955982
[TBL] [Abstract][Full Text] [Related]
16. Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples.
Sibille B; Mothe-Satney I; Le Menn G; Lepouse D; Le Garf S; Baudoin E; Murdaca J; Moratal C; Lamghari N; Chinetti G; Neels JG; Rousseau AS
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768927
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by costunolide in bladder cancer cells is mediated through ROS generation and mitochondrial dysfunction.
Rasul A; Bao R; Malhi M; Zhao B; Tsuji I; Li J; Li X
Molecules; 2013 Jan; 18(2):1418-33. PubMed ID: 23348995
[TBL] [Abstract][Full Text] [Related]
18. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
[TBL] [Abstract][Full Text] [Related]
19. Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer.
Liu YC; Lin KH; Hsieh JH; Chung JG; Tan ZL; Hsu FT; Chiang CH
In Vivo; 2019; 33(6):1865-1877. PubMed ID: 31662514
[TBL] [Abstract][Full Text] [Related]
20. PPARδ agonist enhances colitis-associated colorectal cancer.
Zhou D; Jin J; Liu Q; Shi J; Hou Y
Eur J Pharmacol; 2019 Jan; 842():248-254. PubMed ID: 30391747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
